“The Truth Is, We Must Miss Some”: A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical Trials
Material, organizational, and human factors affect cancer patient eligibility assessment for CTs. Patient-to-trial matching tools bear potential, but good understanding of the ecosystem, including stakeholders' motivations, is a prerequisite.
Authors
- Christophe Tournigand
- B. Baujat (ORCID: https://orcid.org/0000-0003-3930-3191)
- A. La Rosa (ORCID: https://orcid.org/0000-0002-1914-9329)
- B. Campillo‐Gimenez
- Catherine Daniel (ORCID: https://orcid.org/0000-0002-5299-2799)
- Marc Cuggia (ORCID: https://orcid.org/0000-0001-6943-3937)
- Guillaume Lamé (ORCID: https://orcid.org/0000-0001-9514-1890)
- Emmanuelle Kempf (ORCID: https://orcid.org/0000-0002-9285-1966)
- Morgan Vaterkowski
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Sorbonne Université (FR)
- Université Sorbonne Paris Nord (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Laboratoire Traitement du Signal et de l'Image (FR)
- CentraleSupélec (FR)
- Centre Eugène Marquis (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Hôpital Albert-Chenevier (FR)
- Hôpital Tenon (FR)
- Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé
- Université de Rennes (FR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70466
- Citations
- 2
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.09